Sustained-release formulation comprising a glucuronate salt of a piperazine compound and uses thereof

Details for Australian Patent Application No. 2006291060 (hide)

Owner Solvay Pharmaceuticals B.V.

Inventors Shah, Syed Muzafar; Ehrnsperger, Eric C.; Diorio, Christopher R.; Ali, Kadum; Fawzi, Mahdi B.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006291060

PCT Pub. Number WO2007/033193

Priority 60/716,066 12.09.05 US

Filing date 12 September 2006

Wipo publication date 22 March 2007

Acceptance publication date 29 September 2011

International Classifications

A61K 31/538 (2006.01)

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 9/36 (2006.01) Medicinal preparations characterised by special physical form

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/033193 Priority application(s): WO2007/033193

12 June 2008 Assignment before Grant

  Wyeth The application has been assigned to Solvay Pharmaceuticals B.V.

29 September 2011 Application Accepted

  Published as AU-B-2006291060

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006291062-Gaming floor control and configuration system

2006291059-Salicylate and gentisate salts of a piperazine compound